2022956-48-3
Chemical Structure
MOG(35-55) amide, mouse, rat
- CAS. Nr.: 2022956-48-3
- Formula:C118H178N36O28S
- Molecular Weight:2580.97
SMILES: OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N2[C@@H](CCC2)C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(NCC(N[C@H](C(N)=O)CCCCN)=O)=O)=O)=O)CC3=CC=C(C=C3)O)=O)=O)CC4=CN=CN4)=O)=O)=O)=O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)NC([C@@H](NC(CNC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@@H](N)CCSC)=O)=O)=O)=O)CC6=CNC7=CC=CC=C67)=O
Biological Activity: MOG (35-55) amide, mouse, rat the terminal amidation form of the 35-55 fragment of the myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide (MOG (35-55) (HY-P1240)). MOG(35-55) amide, mouse, rat can be used for experimental autoimmune encephalomyelitis (EAE) modeling[1][2][3].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MOG(35-55) amide, mouse, rat | 99.88% | MOG (35-55) amide, mouse, rat the terminal amidation form of the 35-55 fragment of the myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide (MOG (35-55) (HY-P1240)). MOG(35-55) amide, mouse, rat can be used for experimental autoimmune encephalomyelitis (EAE) modeling. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Saligrama N, et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature. 2019 Aug;572(7770):481-487. [Content Brief]
- [2]. Fabiola Puentes, et al. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013 Sep 22:10:118. [Content Brief]
- [3]. 2. Delarasse C, et al. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunology. 2013 Dec;140(4):456-64. [Content Brief]
